Oncology

Building strong relationships with with healthcare professionals in oncology. Syner-Med provides UK Oncology Units with Catheter Management products to improve Clinical Outcomes and enhance patient wellbeing. 

Syner-KINASE® (urokinase) is licensed in the UK for the treatment of occluded catheters and systemic thromboembolic occlusive disease (diseases caused by blood clots).

Citra-Lock™ S (trisodium citrate): Anticoagulant and Antimicrobial catheter lock solution to help maintain catheter patency and reduce catheter related infections. The range of pre-filled syringes contain trisodium citrate locking solution available in 4%, 30% & 46.7%.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to Syner-Med (Pharmaceutical Products) Limited. Tel. +44 020 8655 6380
Subscribe to RSS - Oncology

Leave us a message

CONTACT US

International headquarters
Syner-Med (Pharmaceutical Products) Ltd.
Syner-Med House
120 High Street
Purley, Surrey
CR8 2AD, United Kingdom

Tel: +44 (0)20 8655 6380
E: mail@syner-med.com

Are you a healthcare professional?

To access this section of the Syner-Med Pharmaceutical Products Limited website you need to be a member of the healthcare profession because the materials included in this area of our website are specifically prepared for that audience only.

Please click on the appropriate button below to confirm that you are a healthcare professional. If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.

I am a healthcare professional

I am not a healthcare professional